SGAS: Simplified Gestational Age Score

Sponsor
NICHD Global Network for Women's and Children's Health (Other)
Overall Status
Completed
CT.gov ID
NCT02408783
Collaborator
Massachusetts General Hospital (Other), Lata Medical Research Foundation, Nagpur (Other)
15,920
3
8
5306.7
662

Study Details

Study Description

Brief Summary

A large number of mothers are uncertain of the date of their last menstrual period and where there is a high incidence of small-for-dates babies, there is a real need for a method of estimating gestational age that is both rapid and accurate for early referral and management of preterm newborns to reduce their mortality and morbidity. The National Family Health Survey 2005-06 reports that the proportion of low birth weight babies (LBW) in India is 22%. Of these LBW babies, the proportion of prematurity is not known in the survey as it is difficult to measure gestational age of the newborn due to lack of reliable and valid scores with ease of use at the primary health centers. Different scores to assess maturity have been developed namely New Ballard score, Dubowitz score and Meharban Singh score. It is not known whether these scores have regional, geographical, racial or ethnic robustness. It has also been found that these scores tend to overestimate newborns > 37 weeks and underestimate those

32 and < 37 weeks. The investigators conducted a cross sectional study to validate three neonatal gestational age (GA) assessment scores namely New Ballard, Dubowitz and Meharban Singh with the reference standard i.e. GA assessed by LMP using Naegeles rule and validated by gestational ages also assessed by at least one ultrasound (GA-LMP), in Indian newborns delivered at a tertiary hospital. The investigators derived a new "Simplified Gestational Age Score" (SGAS) using the best applicable items from the three validated scores and assessed its accuracy with the reference standard (GA-LMP). This score has only 4 items (posture, skin texture, breast and genital assessment) and community health workers can be trained in implementing SGAS due to its simplicity. The investigators propose a study in the GN sites to validate this simplified method of assessment of the GA using our SGAS protocol.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    15920 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    Validation of a New Simplified Score for Assessing Gestational Age of Newborns in Community
    Study Start Date :
    Jul 1, 2015
    Actual Primary Completion Date :
    Mar 1, 2016
    Actual Study Completion Date :
    Mar 1, 2016

    Outcome Measures

    Primary Outcome Measures

    1. Validation of score tool [All gestational age assessments will be taken within 24 hours of birth]

      Validity of Simplified Gestational Age Score (SGAS) when used by the ANMs and verified using the GA assessed using LMP and Sonologic GA.

    Secondary Outcome Measures

    1. Variability of observer use of score tool [All gestational age assessments will be taken within 24 hours of birth]

      The inter observer variability in the GA assessed by the ANM and the RO

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Hospital Delivery

    • Live Birth

    • Correct LMP Known

    • At least one USG of Ante-natal Period Reporting GA Available

    • GA by LMP and USG within one week of each other

    • Available for Examination up to 24 Hours of Birth

    • Informed Consent Given

    Exclusion Criteria:
    • Menstrual Cycle Irregular

    • Twin Babies

    • Birth Asphyxia/ baby required Bag and Mask ventilation

    • Major Congenital Anomaly

    • Signs of neurological depression

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Daga Memorial Nagpur India
    2 GH Bhandara Nagpur India
    3 GH Wardha Nagpur India

    Sponsors and Collaborators

    • NICHD Global Network for Women's and Children's Health
    • Massachusetts General Hospital
    • Lata Medical Research Foundation, Nagpur

    Investigators

    • Principal Investigator: Archana Patel, MD, Lata Medical Research Foundation

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    NICHD Global Network for Women's and Children's Health
    ClinicalTrials.gov Identifier:
    NCT02408783
    Other Study ID Numbers:
    • CP SGA
    First Posted:
    Apr 3, 2015
    Last Update Posted:
    Nov 29, 2016
    Last Verified:
    Nov 1, 2016

    Study Results

    No Results Posted as of Nov 29, 2016